The existence of cervical neoplasia among HIV-infected women represents a formidable challenge in the clinical care of immunosuppressed patients due to the expanding global prevalence of HIV infection in women. Increasing access to antiretroviral therapy in resource limited settings and the consequent increasing life-span of HIV-infected persons has necessitated the development of new guidelines for improving their routine preventive healthcare. Preventing the development of human papillomavirus (HPV)-induced high-grade cervical squamous intraepithelial lesions (HSIL) among HIV-infected women needs accurate, reliable and cost-efficient screening tools/methods. Given the limited usefulness of cytology-based screening programs, Visual Inspection with 5% Acetic Acid (VIA) and HPV testing (through self-administered swabs or clinician-collected samples) have been envisioned as cost-effective alternatives for resource-limited settings. Though large scale studies (including community randomized trials) are being conducted to evaluate the effectiveness of these tests, published estimates are devoid of the measures of test performance of these newer tools among HIV-infected women in resource limited settings. This test-of-concept preliminary study is a joint proposal of the University of Alabama at Birmingham (UAB), the National ADDS Research Institute (NARI), Pune, India and Johns Hopkins University (JHU). The study aims 1. To estimate the relative measures of test performance of VIA and HPV-testing in comparison with conventional cytology to detect screen-positive or colposcopy-suggestive, histologically-confirmed HSIL among HIV+ women in Pune, India and 2. To conduct a sub-study to examine the feasibility and acceptability of using self-administered vaginal swabs for HPV-testing and to estimate their accuracy compared to clinician-collected samples among HIV+ women in Pune. 300 HIV-infected women attending women's health clinics in Pune, India using VIA, HPV-testing and Cytology as screening tests and colposcopy as the reference investigation in the same clinic visit. This study will gather preliminary data for the design of a definitive clinical trial that may create a new paradigm for cost-effective cervical cancer screening and treatment strategies for HIV-infected women in resource limited settings as like India.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21CA113465-01
Application #
6893161
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Patriotis, Christos F
Project Start
2005-03-01
Project End
2005-06-30
Budget Start
2005-03-01
Budget End
2005-06-30
Support Year
1
Fiscal Year
2005
Total Cost
$27,942
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Mane, Arati; Sahasrabuddhe, Vikrant V; Nirmalkar, Amit et al. (2017) Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India. J Clin Virol 88:26-32
Sahasrabuddhe, Vikrant V; Parham, Groesbeck P; Mwanahamuntu, Mulindi H et al. (2012) Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila) 5:11-7
Mane, Arati; Nirmalkar, Amit; Risbud, Arun R et al. (2012) HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India. PLoS One 7:e38731
Sahay, Seema; Mehendale, Sanjay (2011) Engaging community to support HIV prevention research. East J Med 16:168-177
Sahasrabuddhe, Vikrant V; Bhosale, Ramesh A; Joshi, Smita N et al. (2010) Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One 5:e8634
Bratcher, Lara F; Sahasrabuddhe, Vikrant V (2010) The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer 5:8
Mwanahamuntu, Mulindi H; Sahasrabuddhe, Vikrant V; Parham, Groesbeck P (2009) HPV screening for cervical cancer in rural India. N Engl J Med 361:305; author reply 306
Sahasrabuddhe, V V; Mwanahamuntu, M H; Vermund, S H et al. (2007) Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 96:1480-3